Recent advances in our ability to identify and characterize the human microbiota have transformed our appreciation of the function of the colon from an organ principally involved in the reabsorption of secretory fluids to a metabolic organ on a par with the liver. High-throughput technology has been applied to the identification of specific differences in microbial DNA, allowing the identification of trillions of microbes belonging to more than 1000 different species, with a metabolic mass of approximately 1.5 kg. The close proximity of these microbes with the mucosa and gut lymphoid tissue helps explain why a balanced microbiota is likely to preserve mucosal health, whereas an unbalanced composition, as seen in dysbiosis, may increase the prevalence of diseases not only of the mucosa but also within the body due to the strong interactions with the gut immune system, the largest immune organ of the body. Such abnormalities have been pinpointed as etiological factors in a wide range of diseases, including autoimmune disorders, allergy, irritable bowel syndrome, inflammatory bowel disease, obesity, and colon cancer. Recognition of the strong potential for food to manipulate microbiota composition has opened up new therapeutic strategies against these diseases based on dietary intervention.
O’HaraAMShanahanF. The gut flora as a forgotten organ. EMBO Rep. 2006;7(7):688-693.
2.
EckburgPBBikEMBernsteinCN. Diversity of the human intestinal microbial flora. Science. 2005;308(5728):1635-1638.
3.
LeyREPetersonDAGordonJI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell. 2006;124(4):837-848.
4.
MackieRISghirAGaskinsHR. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr. 1999;69(5):1035S-1045S.
5.
PalmerCBikEMDiGiulioDBRelmanDABrownPO. Development of the human infant intestinal microbiota. PLoS Biol. 2007;5(7):26.
6.
ZhangHDiBaiseJKZuccoloA. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A. 2009;106(7):2365-2370.
7.
SekirovIRussellSLAntunesLCFinlayBB. Gut microbiota in health and disease. Physiol Rev. 2010;90(3):859-904.
8.
SchlossPDHandelsmanJ. Metagenomics for studying unculturable microorganisms: cutting the Gordian knot. Genome Biol. 2005;6(8):229.
9.
NicholsonJK. Global systems biology, personalized medicine and molecular epidemiology. Mol Syst Biol. 2006;2:52.
10.
QinJLiRRaesJ. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59-65.
11.
WardwellLHHuttenhowerCGarrettWS. Current concepts of the intestinal microbiota and the pathogenesis of infection. Curr Infect Dis Rep. 2011;13(1):28-34.
12.
O’KeefeSJOuJAufreiterS. Products of the colonic microbiota mediate the effects of diet on colon cancer risk. J Nutr. 2009;139(11):2044-2048.
13.
O’KeefeSJ. The colon as a metabolic organ. S Afr Med J. 1994;84(7):376-377.
14.
DrossmanDA. Presidential address: gastrointestinal illness and the biopsychosocial model. Psychosom Med. 1998;60(3):258-267.
15.
BaileyMTDowdSEParryNMGalleyJDSchauerDBLyteM. Stressor exposure disrupts commensal microbial populations in the intestines and leads to increased colonization byCitrobacter rodentium. Infect Immun. 2010;78(4):1509-1519.
16.
ManichanhCVarelaEMartinezC. The gut microbiota predispose to the pathophysiology of acute postradiotherapy diarrhea. Am J Gastroenterol. 2008;103(7):1754-1761.
17.
LiJVAshrafianHBueterM. Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut. 2011;60(9):1214-1223.
18.
O’KeefeSJChungDMahmoudN. Why do African Americans get more colon cancer than native Africans?J Nutr. 2007;137(1)(suppl): 175S-182S.
CummingsJH. Short chain fatty acids in the human colon. Gut. 1981;22(9):763-779.
22.
OuJDeLanyJPZhangMSharmaSO’KeefeSJ. Association between low colonic short-chain fatty acids and high bile acids in high colon cancer risk populations. Nutr Cancer. 2012;64(1):34-40.
23.
NordgaardIMortensenPB. Digestive processes in the human colon. Nutrition. 1995;11(1):37-45.
24.
GrubbenMJvan den BraakCCEssenbergM. Effect of resistant starch on potential biomarkers for colonic cancer risk in patients with colonic adenomas: a controlled trial. Dig Dis Sci. 2001;46(4):750-756.
25.
WargovichMJEngVWNewmarkHL. Calcium inhibits the damaging and compensatory proliferative effects of fatty acids on mouse colon epithelium. Cancer Lett. 1984;23(3):253-258.
26.
WillemsenLEKoetsierMAvan DeventerSJvan TolEA. Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts. Gut. 2003;52(10):1442-1447.
27.
CoxMAJacksonJStantonM. Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines. World J Gastroenterol. 2009;15(44):5549-5557.
28.
BartholomeALAlbinDMBakerDHHolstJJTappendenKA. Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation after an 80% jejunoileal resection in neonatal piglets. JPEN J Parenter Enteral Nutr. 2004;28(4):210-222; discussion 222-223.
29.
LouisPScottKPDuncanSHFlintHJ. Understanding the effects of diet on bacterial metabolism in the large intestine. J Appl Microbiol. 2007;102(5):1197-1208.
30.
RoedigerWE. Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology. 1982;83(2):424-429.
31.
WatsonAJ. An overview of apoptosis and the prevention of colorectal cancer. Crit Rev Oncol Hematol. 2006;57(2):107-121.
32.
Rodriguez-CabezasMEGalvezJLorenteMD. Dietary fiber down-regulates colonic tumor necrosis factor alpha and nitric oxide production in trinitrobenzenesulfonic acid–induced colitic rats. J Nutr. 2002;132(11):3263-3271.
33.
NguyenKACaoYChenJRTownsendCMJrKoTC. Dietary fiber enhances a tumor suppressor signaling pathway in the gut. Ann Surg. 2006;243(5):619-625.
34.
KimYSMilnerJA. Dietary modulation of colon cancer risk. J Nutr. 2007;137(11)(suppl):2576S-2579S.
35.
PrydeSEDuncanSHHoldGLStewartCSFlintHJ. The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett. 2002;217(2):133-139.
36.
DavieJR. Inhibition of histone deacetylase activity by butyrate. J Nutr. 2003;133(7)(suppl):2485S-2493S.
37.
GreerJBO’KeefeSJ. Microbial induction of immunity, inflammation, and cancer. Front Physiol. 2011;1:168.
38.
EbertMNKlinderAPetersWH. Expression of glutathione S-transferases (GSTs) in human colon cells and inducibility of GSTM2 by butyrate. Carcinogenesis. 2003;24(10):1637-1644.
39.
AndohAShimadaMArakiYFujiyamaYBambaT. Sodium butyrate enhances complement-mediated cell injury via down-regulation of decay-accelerating factor expression in colonic cancer cells. Cancer Immunol Immunother. 2002;50(12):663-672.
40.
ZgourasDWachtershauserAFringsDSteinJ. Butyrate impairs intestinal tumor cell–induced angiogenesis by inhibiting HIF-1alpha nuclear translocation. Biochem Biophys Res Commun. 2003;300(4):832-838.
41.
PicheTdes VarannesSBSacher-HuvelinSHolstJJCuberJCGalmicheJP. Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease. Gastroenterology. 2003;124(4): 894-902.
42.
ZhouJHegstedMMcCutcheonKL. Peptide YY and proglucagon mRNA expression patterns and regulation in the gut. Obesity (Silver Spring). 2006;14(4):683-689.
43.
KienCLKepnerJGrotjohnKAultKMcCleadRE. Stable isotope model for estimating colonic acetate production in premature infants. Gastroenterology. 1992;102(5):1458-1466.
44.
PuchowiczMABedermanIRComteB. Zonation of acetate labeling across the liver: implications for studies of lipogenesis by MIDA. Am J Physiol. 1999;277(6, pt 1):E1022-E1027.
45.
VenterCSVorsterHHCummingsJH. Effects of dietary propionate on carbohydrate and lipid metabolism in healthy volunteers. Am J Gastroenterol. 1990;85(5):549-553.
46.
RodwellVWNordstromJLMitschelenJJ. Regulation of HMG-CoA reductase. Adv Lipid Res. 1976;14:1-74.
47.
Al-LahhamSHPeppelenboschMPRoelofsenHVonkRJVenemaK. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim Biophys Acta. 2010;1801(11):1175-1183.
48.
DannhardtGLehrM. Nonsteroidal antiinflammatory agents, XVII: inhibition of bovine cyclooxygenase and 5-lipoxygenase by N-alkyldiphenyl-pyrrolyl acetic and propionic acid derivatives. Arch Pharm (Weinheim). 1993;326(3):157-162.
49.
Zapolska-DownarDNaruszewiczM. Propionate reduces the cytokine-induced VCAM-1 and ICAM-1 expression by inhibiting nuclear factor-kappa B (NF-kappaB) activation. J Physiol Pharmacol. 2009; 60(2):123-131.
50.
LawhonSDMaurerRSuyemotoMAltierC. Intestinal short-chain fatty acids alter Salmonella typhimurium invasion gene expression and virulence through BarA/SirA. Mol Microbiol. 2002;46(5):1451-1464.
51.
RuijschopRMAJBoelrijkAEMte GiffelaMC. Satiety effects of a dairy beverage fermented with propionic acid bacteria. Int Dairy J. 2008;18: 945-950.
52.
Al-LahhamSHRoelofsenHPriebeM. Regulation of adipokine production in human adipose tissue by propionic acid. Eur J Clin Invest. 2010;40(5):401-407.
53.
CebraJJPeriwalSBLeeGLeeFShroffKE. Development and maintenance of the gut-associated lymphoid tissue (GALT): the roles of enteric bacteria and viruses. Dev Immunol. 1998;6(1-2):13-18.
54.
WellsJMRossiOMeijerinkMvan BaarlenP. Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci U S A. 2011;108(suppl 1):4607-4614.
55.
AbreuMT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol. 2010;10(2):131-144.
56.
WellsJMRossiOMeijerinkMvan BaarlenP. Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci U S A. 2011;1:4607-4614.
57.
O’KeefeSJ. Nutrition and colonic health: the critical role of the microbiota. Curr Opin Gastroenterol. 2008;24(1):51-58.
58.
GibsonGRCummingsJHMacfarlaneGT. Competition for hydrogen between sulphate-reducing bacteria and methanogenic bacteria from the human large intestine. J Appl Bacteriol. 1988;65(3):241-247.
59.
Attene-RamosMSWagnerEDGaskinsHRPlewaMJ. Hydrogen sulfide induces direct radical-associated DNA damage. Mol Cancer Res. 2007;5(5):455-459.
60.
GibsonGRMacfarlaneGTCummingsJH. Sulphate reducing bacteria and hydrogen metabolism in the human large intestine. Gut. 1993;34(4):437-439.
61.
NagengastFMGrubbenMJvan MunsterIP. Role of bile acids in colorectal carcinogenesis. Eur J Cancer. 1995;31A(7-8):1067-1070.
62.
RidlonJMKangDJHylemonPB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res. 2006;47(2):241-259.
63.
ChengKRaufmanJP. Bile acid–induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors. Biochem Pharmacol. 2005;70(7):1035-1047.
64.
PayneCMCrowley-SkillicornCBernsteinCHolubecHMoyerMPBernsteinH. Hydrophobic bile acid–induced micronuclei formation, mitotic perturbations, and decreases in spindle checkpoint proteins: relevance to genomic instability in colon carcinogenesis. Nutr Cancer. 2010;62(6):825-840.
65.
BalamuruganRRajendiranEGeorgeSSamuelGVRamakrishnaBS. Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer. J Gastroenterol Hepatol. 2008;23(8, pt 1):1298-1303.
66.
SobhaniITapJRoudot-ThoravalF. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One. 2011;6(1):e16393.
67.
CastellarinMWarrenRLFreemanJD. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma [published online ahead of print October 18, 2011]. Genome Res. doi:10.1101/gr.126516.11110.1101/gr.126516.111.
68.
McLeanMHMurrayGIStewartKN. The inflammatory microenvironment in colorectal neoplasia. PLoS One. 2011;6(1):e15366.
69.
WuSRheeKJAlbesianoE. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med. 2009;15(9):1016-1022.
70.
AbdulamirASHafidhRRAbu BakarF. The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role. J Exp Clin Cancer Res. 2011;30:11.
71.
TsilidisKKBranchiniCGuallarEHelzlsouerKJErlingerTPPlatzEA. C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Int J Cancer. 2008;123(5):1133-1140.
72.
DinFVTheodoratouEFarringtonSM. Effect of aspirin and NSAIDs on risk and survival from colorectal cancer. Gut. 2010;59(12):1670-1679.
73.
SwidsinskiAKhilkinMKerjaschkiD. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology. 1998;115(2):281-286.
74.
HuyckeMMGaskinsHR. Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp Biol Med (Maywood). 2004;229(7):586-597.
75.
OnoueMKadoSSakaitaniYUchidaKMorotomiM. Specific species of intestinal bacteria influence the induction of aberrant crypt foci by 1,2-dimethylhydrazine in rats. Cancer Lett. 1997;113(1-2):179-186.
76.
de VogelJvan-EckWBSesinkALJonker-TermontDSKleibeukerJvan der MeerR. Dietary heme injures surface epithelium resulting in hyperproliferation, inhibition of apoptosis and crypt hyperplasia in rat colon. Carcinogenesis. 2008;29(2):398-403.
77.
WuKGiovannucciEByrneC. Meat mutagens and risk of distal colon adenoma in a cohort of U.S. men. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1120-1125.
78.
McMillanLButcherSWallisYNeoptolemosJPLordJM. Bile acids reduce the apoptosis-inducing effects of sodium butyrate on human colon adenoma (AA/C1) cells: implications for colon carcinogenesis. Biochem Biophys Res Commun. 2000;273(1):45-49.
79.
de VogelJJonker-TermontDSvan LieshoutEMKatanMBvan der MeerR. Green vegetables, red meat and colon cancer: chlorophyll prevents the cytotoxic and hyperproliferative effects of haem in rat colon. Carcinogenesis. 2005;26(2):387-393.
80.
TodenSBirdARToppingDLConlonMA. Resistant starch prevents colonic DNA damage induced by high dietary cooked red meat or casein in rats. Cancer Biol Ther. 2006;5(3):267-272.
81.
YoungVBSchmidtTM. Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J Clin Microbiol. 2004;42(3):1203-1206.
82.
ReevesAETheriotCMBerginILHuffnagleGBSchlossPDYoungVB. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile infection. Gut Microbes. 2011;2(3):145-158.
83.
KhorutsADicksvedJJanssonJKSadowskyMJ. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile–associated diarrhea. J Clin Gastroenterol. 2010;44(5):354-360.
84.
LoftusEVJr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126(6):1504-1517.
85.
StrachanDP. Hay fever, hygiene, and household size. BMJ. 1989; 299(6710):1259-1260.
86.
FavaFDaneseS. Intestinal microbiota in inflammatory bowel disease: friend of foe?World J Gastroenterol. 2011;17(5):557-566.
87.
RoedigerWEDuncanAKapanirisOMillardS. Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. Gastroenterology. 1993;104(3):802-809.
88.
WangMKarlssonCOlssonC. Reduced diversity in the early fecal microbiota of infants with atopic eczema. J Allergy Clin Immunol. 2008;121(1):129-134.
89.
McLoughlinRMMillsKH. Influence of gastrointestinal commensal bacteria on the immune responses that mediate allergy and asthma. J Allergy Clin Immunol. 2011;127(5):1097-1107; quiz 1108-1109.
90.
PendersJStobberinghEEvan den BrandtPAThijsC. The role of the intestinal microbiota in the development of atopic disorders. Allergy. 2007;62(11):1223-1236.
91.
PendersJStobberinghEEThijsC. Molecular fingerprinting of the intestinal microbiota of infants in whom atopic eczema was or was not developing. Clin Exp Allergy. 2006;36(12):1602-1608.
92.
SaulnierDMRiehleKMistrettaTA. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology. 2011;141(5):1782-1791.
93.
Rajilic-StojanovicMBiagiEHeiligHG. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology. 2011;141(5):1792-1801.
94.
LeeBJBakYT. Irritable bowel syndrome, gut microbiota and probiotics. J Neurogastroenterol Motil. 2011;17(3):252-266.
95.
LeyREBackhedFTurnbaughPLozuponeCAKnightRDGordonJI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005;102(31):11070-11075.
96.
TurnbaughPJLeyREMahowaldMAMagriniVMardisERGordonJI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027-1031.
97.
TurnbaughPJBackhedFFultonLGordonJI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008;3(4):213-223.
98.
LeyRETurnbaughPJKleinSGordonJI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444(7122):1022-1023.
99.
SchwiertzATarasDSchaferK. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring). 2010;18(1): 190-195.
100.
GreinerTBackhedF. Effects of the gut microbiota on obesity and glucose homeostasis. Trends Endocrinol Metab. 2011;22(4):117-123.
101.
CaniPDBibiloniRKnaufC. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008;57(6):1470-1481.
102.
Abu-ShanabAQuigleyEM. The role of the gut microbiota in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2010;7(12): 691-701.
103.
MutluEKeshavarzianAEngenPForsythCBSikaroodiMGillevetP. Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. Alcohol Clin Exp Res. 2009;33(10):1836-1846.
104.
CapoorMRNairDRajni. Microflora of bile aspirates in patients with acute cholecystitis with or without cholelithiasis: a tropical experience. Braz J Infect Dis. 2008;12(3):222-225.
105.
AbeysuriyaVDeenKIWijesuriyaTSalgadoSS. Microbiology of gallbladder bile in uncomplicated symptomatic cholelithiasis. Hepatobiliary Pancreat Dis Int. 2008;7(6):633-637.
106.
ZhaoHYWangHJLuZXuSZ. Intestinal microflora in patients with liver cirrhosis. Chin J Dig Dis. 2004;5(2):64-67.
107.
LiuQDuanZPHaDKBengmarkSKurtovicJRiordanSM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology. 2004;39(5):1441-1449.
108.
SudoNChidaYAibaY. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol. 2004;558(pt 1):263-275.
109.
CryanJFO’MahonySM. The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil. 2011;23(3):187-192.
110.
NeufeldKMKangNBienenstockJFosterJA. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil. 2011;23(3):255-264, e119.
